Edition:
India

Neovasc Inc (NVCN.OQ)

NVCN.OQ on NASDAQ Stock Exchange Capital Market

0.04USD
19 Jul 2018
Change (% chg)

$0.00 (+4.41%)
Prev Close
$0.03
Open
$0.03
Day's High
$0.04
Day's Low
$0.03
Volume
1,176,705
Avg. Vol
9,908,425
52-wk High
$1.88
52-wk Low
$0.03

Latest Key Developments (Source: Significant Developments)

Neovasc Announces Appointment Of Steve Rubin As Chairman Of The Board
Monday, 11 Jun 2018 

June 11 (Reuters) - Neovasc Inc ::NEOVASC ANNOUNCES APPOINTMENT OF STEVE RUBIN AS CHAIRMAN OF THE BOARD AND GENERAL UPDATE.NEOVASC INC - STEVE RUBIN SUCCEEDS PAUL GEYER, WHO WILL REMAIN A DIRECTOR OF BOARD.  Full Article

Neovasc's Management And Board Of Directors Urge Shareholders To Vote In Favor Of The Proposed Reverse Stock Split
Tuesday, 15 May 2018 

May 15 (Reuters) - Neovasc Inc ::NEOVASC'S MANAGEMENT AND BOARD OF DIRECTORS URGE SHAREHOLDERS TO VOTE IN FAVOR OF THE PROPOSED REVERSE STOCK SPLIT AT THE UPCOMING ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS.NEOVASC INC - MANAGEMENT BELIEVES THAT IT IS IN BEST INTEREST OF COMPANY AND ITS STAKEHOLDERS TO REMAIN ON NASDAQ.  Full Article

Fred Colen Appointed CEO Of Neovasc Inc
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Neovasc Inc ::FRED COLEN APPOINTED CHIEF EXECUTIVE OFFICER OF NEOVASC INC..NEOVASC INC - ‍ ALEXEI MARKO, NEOVASC'S OUTGOING CEO, WILL MAINTAIN HIS ROLE AS A DIRECTOR​.NEOVASC INC - ‍COLEN MOST RECENTLY SERVED AS PRESIDENT AND CHIEF EXECUTIVE OFFICER OF BENECHILL​.  Full Article

Capital World Investors Reports A 13.8 Percent Passive Stake In Neovasc Inc
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Neovasc Inc ::CAPITAL WORLD INVESTORS REPORTS A 13.8 PERCENT PASSIVE STAKE IN NEOVASC INC AS OF NOVEMBER 30, 2017 - SEC FILING.  Full Article

Neovasc announces 65 million dollars offering of common shares and warrants
Friday, 10 Nov 2017 

Nov 10 (Reuters) - NEOVASC INC ::NEOVASC ANNOUNCES US$65 MILLION UNDERWRITTEN OFFERING OF UNITS CONSISTING OF COMMON SHARES AND WARRANTS TO PURCHASE COMMON SHARES AND CONCURRENT PRIVATE PLACEMENT OF NOTES AND WARRANTS.‍PRICE OF US$1.46 PER UNIT FOR GROSS PROCEEDS OF APPROXIMATELY US$37.487 MILLION​.WILL ALSO COMPLETE BROKERED PRIVATE PLACEMENT FOR SALE OF US$32,750,000 AGGREGATE PRINCIPAL AMOUNT OF SENIOR SECURED CONVERTIBLE NOTES FOR GROSS PROCEEDS OF US$27,837,500​.‍ CANACCORD GENUITY INC. IS ACTING AS SOLE BOOK-RUNNING MANAGER FOR OFFERING​.‍CANACCORD GENUITY INC ACTS ALSO AS SOLE PLACEMENT AGENT FOR CONCURRENT PRIVATE PLACEMENT​.  Full Article

Neovasc receives FDA approval to initiate pivotal reducer trial
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Neovasc Inc :Neovasc receives FDA approval to initiate pivotal reducer trial.Neovasc Inc - ‍Co is currently evaluating start up timelines and funding options for Cosira-II trial​.  Full Article

Neovasc provides litigation update
Saturday, 4 Nov 2017 

Nov 3 (Reuters) - Neovasc Inc :Neovasc provides litigation update.Says Court Of Appeals affirmed judgment of U.S. District Court for District of Massachusetts in case of Cardiaq Valve Tech versus co.Says ‍full judgment of about US$112 million will now become due on November 13, 2017​.  Full Article

Neovasc and Boston Scientific closes $75 million agreement
Tuesday, 13 Dec 2016 

Neovasc Inc - : On Dec 12, U.S. District court for district of Massachusetts held hearing in connection with co's litigation against cardiaq . Court denied cardiaq's motion for temporary restraining order to prevent deal between neovasc and boston scientific corporation from closing . Court also indicated a willingness to stay enforcement of judgment against neovasc pending appeal .Stay enforcement subject to neovasc posting a partial bond in amount of US$70 million.  Full Article

Neovasc announces update in litigation with CardiAQ
Tuesday, 1 Nov 2016 

Neovasc Inc : Neovasc announces update in litigation with CardiAQ . Says in order, judge ruled in favor of cardiAQ on issue of inventorship of neovasc's '964 patent . Says at same time, judge denied CardiAQ's motion for an injunction that would have shut down development of tiara . Neovasc inc says the judge upheld jury's verdict and $70 million award against co, and awarded $21 million in enhanced damages to that award . Says believe this decision affirms Neovasc's rights to advance tiara program . Neovasc inc says upon entry of a judgment by trial court, co will immediately seek to stay payment of $70 million damages award .Says it will appeal validity of award, as well as ruling on inventorship.  Full Article

Neovasc Inc qtrly loss per share $1.25
Wednesday, 10 Aug 2016 

Neovasc Inc : Qtrly loss per share $1.25 . Circumstances relating to cardiaq litigation cast substantial doubt about company's ability to continue as a going concern .Revenues for three months ended june 30, 2016 were $1.7 million compared to revenues of $3 million.  Full Article

BRIEF-Neovasc Receives German Nub Status 1 Designation For Neovasc Reducer Procedure

* NEOVASC ANNOUNCES RECEIPT OF GERMAN NUB STATUS 1 DESIGNATION FOR NEOVASC REDUCER™ PROCEDURE FOR TREATMENT OF REFRACTORY ANGINA Source text for Eikon: Further company coverage: